Chu, Jianhong <br/><br/>
Genetic modification of T cells redirected toward CS1 enhances eradication of myeloma cells.  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  Aug 2014 
 - 3989-4000 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1557-3265 
<br/><br/><label>Standard No.: </label>10.1158/1078-0432.CCR-13-2510  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Blotting, Western<br/>Cytotoxicity, Immunologic--immunology<br/>Flow Cytometry<br/>Genetic Engineering<br/>Humans<br/>Interleukin Receptor Common gamma Subunit<br/>Male<br/>Mice<br/>Mice, Inbred NOD<br/>Mice, SCID<br/>Multiple Myeloma--immunology<br/>Receptors, Antigen, T-Cell--genetics<br/>Receptors, Immunologic--genetics<br/>Signaling Lymphocytic Activation Molecule Family<br/>T-Lymphocytes--immunology<br/>Tumor Cells, Cultured<br/>Xenograft Model Antitumor Assays